Recognizing Pain Intensity in Alzheimer's Disease
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Oct 29, 2020
Trial Information
Current as of April 29, 2025
Terminated
Keywords
ClinConnect Summary
It will therefore be a question of inducing experimental pain in patients with Alzheimer's disease, in the early stages of the disease and to check whether pain-related changes in the autonomic nervous system via the Nociception Level index (NoL® system) differ from a control group of subjects matched in age, gender and education level. To induce pain, the investigators will use the "cold pressor test" technique, which consists of leaving the arm immersed in ice water for as long as the pain is bearable. The investigators will also record before, during and after the immersion, the variatio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria for patients with alzheimer's disease :
- • Diagnosis of the disease by a hospital doctor after an etiological assessment including at least a cerebral MRI, a neuropsychological assessment and, if possible, dementia markers in the cerebrospinal fluid.
- • Mini Mental State Score \> 23
- Inclusion Criteria for control subject :
- • - Matching by age (± 5 years), gender, and grade level
- Exclusion Criteria for 2 groups :
- • presence of pain,
- • Presence of mood and/or psychiatric disorders (HAD A ou A scores \>7).
- • Presence of cardiovascular risk factors and beta-blocker and/or calcium channel blocker therapy.
- • Patients under guardianship or curatorship
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
Céline BORG, MD
Principal Investigator
CHU of Saint Etienne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials